R.PR
REGISTERED-PRINCIPAL REGISTER
05/04/2022
Voltar para busca
Dado oficial do USPTO
SYNGENE SYNVENT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
05/04/2022
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
42, 44
Data de depósito
21/07/2020
Data de registro
05/04/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/04/2022
Última transação
05/04/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
11/08/2021
Primeiro uso no comércio
11/08/2021
Código do desenho
3
Tipo de titular
99
Localização do titular
Karnataka, IN
Examinador
BLACK, MILDRED
Unidade examinadora
N30
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the word "SYNGENE", in a smaller font, above the right half of the word "SYNVENT", the word "SYNVENT" having the the outline of the letter "V" within a solid circle.
Titulares e representantes
Titulares
Syngene International Limited
Representantes
Mark A. Watkins VORYS, SATER, SEYMOUR AND PEASE LLP
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Scientific research and custom synthesis; scientific and clinical research in the field of medicinepharmaceuticalnutraceuticals; scientific research and development; custom design and development of chemical reagents and biochemical assays; laboratory testing services for research purposes; testing of pharmaceuticals; chemical engineering; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; scientific study and research in the field of reproductionhusbandrygeneral health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodiesantibody technology; custom design and development of chemical reagents and biochemical assays; designengineeringresearchdevelopment and testing services in the field of polymeric materialspolymer synthesismaterials customization for medicalscientifictechnological applications; toxicology services; toxicity analysis; toxicity testing for research purposes; conducting clinical trials for scientific research for others; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific and medical laboratory services; services of a chemical and/or biological laboratory; laboratory research services relating to pharmaceuticals; research and development and consultation related thereto in the field of antibodiesantibody technologychemistrybioinformaticsbiomedical devicesbiologicsbiotechnologybiotherapeuticsbiologybiochemical preparationscell linechemoinformaticgenetics and genetic engineeringgene expression systemsin vitro researchinhalation pharmaceuticalsmolecular sciencesmicro-organismsnutritionophthalmic preparationspharmacogeneticspharmacokineticspharmacologypharmaceuticalspolymerpeptide synthesisproteinsolid state characterization; toxicokinetic analysis and toxicology services; scientific and technological servicesscientific researchdevelopmentanalysistestingengineeringextractionsynthesispurification and production in the field of antibodiesactive pharmaceutical ingredients (API)biomoleculescell bank characterizationchiralitychromosome aberrationclinical chemistrycloning vectorcyclotidesDNAflow cytometrygas chromatography mass spectrometrygenesimmuno-pharmaceuticalsin vitro irritationlarge moleculeliquid chromatography mass spectrometrymicrobialsmonomersnanoparticlesnatural productspeptidesproteinsRNAsupercritical fluid chromatographysmall molecules and vaccines; none of the aforesaid services relating to gel imaging and gel analysis applications and none of the aforesaid services in the field of agriculturehorticulture and forestry
Classe 44
Medical diagnostic testingmonitoring and reporting services; preparation of reports relating to medical matters; services for the testing of urine; pathology services for medical and diagnostic purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/03/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/03/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
15/02/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
14/02/2022
IUAF
USE AMENDMENT FILED
27/01/2022
EISU
TEAS STATEMENT OF USE RECEIVED
27/01/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
27/07/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/06/2021
PUBO
PUBLISHED FOR OPPOSITION
01/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/05/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/04/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
29/04/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
29/04/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
29/04/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
29/04/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/11/2020
GNRT
NON-FINAL ACTION E-MAILED
09/11/2020
CNRT
NON-FINAL ACTION WRITTEN
09/11/2020
DOCK
ASSIGNED TO EXAMINER
04/11/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
19/08/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/08/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29/07/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/07/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
29/07/2020
NWAP
NEW APPLICATION ENTERED
24/07/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SYNGENE SYNVENT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.